Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix

Current Opinion in Oncology

Volumn 13, Issue 5, 2001, Pages 394-398

  Shipman, Suzanne Davey ^a   Bristow, Robert E ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; CANCER CYTODIAGNOSIS; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; PAPANICOLAOU TEST; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION;

ADENOCARCINOMA; CARCINOMA IN SITU; CELL TRANSFORMATION, NEOPLASTIC; CONIZATION; FEMALE; HUMANS; MASS SCREENING; NEOPLASM INVASIVENESS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034844589     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200109000-00014     Document Type: Review

References (29)

1. Adenocarcinoma in situ of the uterine cervix
2. The significance of atypical glandular cells on routine cytologic testing in a community-based population
3. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears
4. Atypical glandular cells of undetermined significance: Clinically significant lesions and means of patient follow-up
5. Clinical evaluation of atypical glandular cells of undetermined significance
6. Subdividing atypical glandular cells of undetermined significance according to the Australian modified Bethesda system
7. Endocervical atypical glandular cells of undetermined significance. I. Morphometric and cytologic characterization that "cannot rule out adenocarcinoma in situ"
8. ThinPrep Pap test accuracy for glandular disease
9. Comparison of ThinPrep and Pap smear in relation to prediction of adenocarcinoma in situ
10. Cell block preparation by inverted filter sedimentation is useful in the differential diagnosis of atypical glandular cells of undetermined significance in ThinPrep specimens
11. Adenocarcinoma in situ of the uterine cervix
12. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease
13. Adenocarcinoma in situ of the cervix: Significance of cone biopsy margins
14. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix
15. Adenocarcinoma in situ of the cervix-the margins must be clear
16. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ
17. Adenocarcinoma in situ of the uterine cervix: Management and outcome
18. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix
19. Adenocarcinoma in situ of the cervix: Management and outcome
20. The anatomic distribution of cervical adenocarcinoma in situ: Implications for treatment
21. Adenocarcinoma in situ of the cervix
22. A clinicopathologic study of adenocarcinoma in situ of the cervix. The influence of cervical HPV infection and other factors, and the role of conservative surgery
23. Adenocarcinoma in situ of the uterine cervix: An experience with 100 cases
24. Conservative management of adenocarcinoma in situ of the cervix
25. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ
26. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix
27. Early invasive adenocarcinoma of the cervix: A histopathologic analysis of 40 cases with observations concerning histogenesis
28. Early invasive adenocarcinoma of the uterine cervix
29. Prospective management of stage IA1 cervical adenocarcinoma by conization alone to preserve fertility: A preliminary report